Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

An elderly Chinese man lost all his hair after taking a new heart medication.

Amlodipine impairs fertility in male rats by affecting sperm and testicular structure.

Spironolactone is a safe and effective hair loss treatment, especially with minoxidil.

Spironolactone effectively treats female pattern hair loss but requires ongoing use to maintain results.

Some blood pressure medications are linked to a higher risk of skin cancer.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Anti-androgens might help reduce COVID-19 severity in men.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Synthetic hormone treatment reduces melanin and hair growth in rats.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Clascoterone may be an effective topical treatment for hair loss.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Spironolactone for skin issues rarely causes low blood pressure.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Minoxidil lowers blood pressure more effectively but has more side effects, so try hydralazine first.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Monitoring potassium levels is important for women taking spironolactone.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.